Compass Therapeutics, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Compass Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2019 to 2023.
  • Compass Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $2.12M, a 30.3% increase year-over-year.
  • Compass Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $7.35M, a 41.1% increase year-over-year.
  • Compass Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $6.12M, a 14.8% increase from 2022.
  • Compass Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $5.33M, a 32.3% increase from 2021.
  • Compass Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $4.03M, a 0.32% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $6.12M +$790K +14.8% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-21
2022 $5.33M +$1.3M +32.3% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-21
2021 $4.03M +$13K +0.32% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-15
2020 $4.02M +$3.1M +339% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-18
2019 $915K Jan 1, 2019 Dec 31, 2019 10-K 2021-03-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.